Comparison between Mahamaya Lifesciences IPO and Saffron Speciality Papers IPO.
Mahamaya Lifesciences IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Saffron Speciality Papers IPO is a SME Bookbuilding proposed to list at BSE SME.
| Mahamaya Lifesciences IPO | Saffron Speciality Papers IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Oneview Corporate Advisors Pvt.Ltd. | BOI Merchant Bankers Ltd. |
| Registrar | Kfin Technologies Ltd. | NSDL Database Management Ltd. |
| Market Maker | ||
| DRHP | DRHP  | DRHP |
| RHP | ||
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Mahamaya Lifesciences IPO is up to ₹0.00 Cr whereas the issue size of the Saffron Speciality Papers IPO is up to ₹0.00 Cr. The final issue price of Mahamaya Lifesciences IPO is and of Saffron Speciality Papers IPO is .
| Mahamaya Lifesciences IPO | Saffron Speciality Papers IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 56,38,800 shares | 54,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 5,40,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 61,78,800 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Mahamaya Lifesciences IPO opens on , while Saffron Speciality Papers IPO opens on . The closing date of Mahamaya Lifesciences IPO and Saffron Speciality Papers IPO is , and , respectively.
| Mahamaya Lifesciences IPO | Saffron Speciality Papers IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | ||
| Issue Close | ||
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Mahamaya Lifesciences IPO P/E ratio is , as compared to Saffron Speciality Papers IPO P/E ratio of .
| Mahamaya Lifesciences IPO | Saffron Speciality Papers IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Mahamaya Lifesciences Limited Financial Information (Restated Consolidated)
| Saffron Speciality Papers Limited Financial Information (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 77.27 | 89.41 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 23.67% | 32.84% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 32.38% | 21.91% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 5.89 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 21.16% | 32.84% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Mahamaya Lifesciences IPO Retail Individual Investors (RII) are offered while in Saffron Speciality Papers IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Mahamaya Lifesciences IPO and in Saffron Speciality Papers IPO.
| Mahamaya Lifesciences IPO | Saffron Speciality Papers IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Mahamaya Lifesciences IPO subscribed in total, whereas Saffron Speciality Papers IPO subscribed .
| Mahamaya Lifesciences IPO | Saffron Speciality Papers IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
